Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 233-546-5 | CAS number: 10226-30-9
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Acute Toxicity: oral
Administrative data
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- From February 10th to march 8th, 2016
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 016
- Report date:
- 2016
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 420 (Acute Oral Toxicity - Fixed Dose Method)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.1 bis (Acute Oral Toxicity - Fixed Dose Procedure)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Test type:
- fixed dose procedure
- Limit test:
- no
Test material
- Reference substance name:
- 6-chlorohexan-2-one
- EC Number:
- 233-546-5
- EC Name:
- 6-chlorohexan-2-one
- Cas Number:
- 10226-30-9
- Molecular formula:
- C6H11ClO
- IUPAC Name:
- 6-chlorohexan-2-one
- Test material form:
- liquid
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Wistar
- Remarks:
- (Cmdb: WI; outbred)
- Sex:
- female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Husbandry of laboratory animals of the Experimental Medicine Centre at the Medical University in Białystok.
- Age and weight at study initiation: One 9-week-old animal weighing 233.0 g (dose of 300 mg/kg bw), and one 10-week-old animal weighing 220.0 g (dose of 2000 mg/kg bw) were used in the preliminary experiment. Four 11-week-old animals whose average body weight was 228.5 g (dose of 2000 mg/kg b.w.) were used in the main experiment.
- Fasting period before study: 19 hours
- Housing: The animals were kept in plastic cages covered with wire bar lids. The dimensions of the cages were 58 x 37 x 21 cm. In the preliminary experiment, the animals were caged individually. In the main experiment, there were four animals in one cage. UV-sterilized wood shavings were used as bedding. The environment of the animals was enriched by placing wooden blocks and nesting materials for laboratory animals in the cages.
- Diet (e.g. ad libitum): Murigran standard granulated laboratory fodder ad libitum.
- Water (e.g. ad libitum): tap water ad libitum.
- Acclimation period: 5 days.
ENVIRONMENTAL CONDITIONS
- Temperature: 20-23ºC
- Humidity: 27-50%
- Air changes: 16 times/hour
- Photoperiod: 12 hours light/12 hours dark
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- corn oil
- Details on oral exposure:
- VEHICLE
- Concentration in vehicle: 60mg/mL (300 mg/kg bw) and 400 mg/mL (2000 mg/kg bw)
- Amount of vehicle (if gavage): 0.5 mL/100 g bw
- Justification for choice of vehicle: Low water solubility.
- Other: The suspensions were prepared on the administration day (shortly before the administration).
CLASS METHOD (if applicable)
- Rationale for the selection of the starting dose: The starting dose for the sighting study was selected from the fixed dose levels of 5, 50, 300, and 2000 mg/kg bw as a dose expected to produce evident toxicity. Since no data were available, the sighting study commenced with the administration of the test item at a dose of 300 mg/kg bw to one female rat. Since no evident toxicity was produced, the test item at a single dose of 2000 mg/kg bw was administered to the second animal. On the grounds of the sighting study results (no evidence toxicity), the dose of 2000 mg/kg bw was selected to be used in the main study. - Doses:
- Sighting study: 300 and 2000 mg/kg bw
Main study: 2000 mg/kg bw - No. of animals per sex per dose:
- 1 female for the preliminary experiment at 300 mg/kg bw.
5 females (included the one from preliminary) for the main experiment at 2000 mg/kg bw - Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: General condition of the animals at least once a day, clinical detailed observations on day 0: 10, 30 and 60 minutes after the administration and then at hourly intervals up to 5th hour after administration. Thereafter once a day from the day 1 to the day 14.
Weight was determined on day 0 (directly before administration),7 and 14 before euthanasia.
- Necropsy of survivors performed: yes
Results and discussion
- Preliminary study:
- No evident toxicity was observed in dose 300 mg/kg bw and the animal survived the experiment. Following single administration of the test item at a dose of 2000 mg/kg bw, the following changes were observed: the rounded back, wavering gait, slightly, then distinct decreased locomotor activity, animal could be very east to catch, and dejection and bristled coat. The animal survived the experiment.
Effect levels
- Key result
- Sex:
- female
- Dose descriptor:
- LD50
- Effect level:
- > 2 000 mg/kg bw
- Based on:
- test mat.
- Mortality:
- No mortalities were recorded, all animals survived the experiment.
- Clinical signs:
- On the day of administration of the test item, rounded back, wavering gait, and slightly decreased locomotor activity was observed.
- Body weight:
- Body weight gain was observed in all animals. See table 1 on "Any other information on results incl. tables"
- Gross pathology:
- Gross examinations did not reveal any pathological changes in the examined animals.
Any other information on results incl. tables
Table 1. Body weight of the animals (g) overall list
Dose (mg/kg body weight) |
Animal number |
Body weight (g) |
Body weight gain (g) 0 to 14 |
|||
Day of the experiment |
||||||
0 |
7 |
14 |
||||
300 |
1* |
233 |
267 |
279 |
46 |
|
2000 |
1* |
220 |
242 |
259 |
39 |
|
2 |
233 |
260 |
266 |
33 |
||
3 |
225 |
227 |
237 |
10 |
||
4 |
221 |
247 |
255 |
34 |
||
5 |
235 |
251 |
262 |
27 |
*Female from the preliminary experiment.
Table 2. Summary of results.
Dose of test item (mg/kg b.w.) |
300 |
2000 |
|
Preliminary experiment |
Preliminary experiment |
Main experiment |
|
Mortality |
0/1 |
0/1 |
0/4 |
Clinical signs |
Not stated |
rounded back, wavering gait, slight and then distinct decreases of locomotor activity, animal was very easy to catch, dejection, bristled coat. |
In all animals: rounded back, wavering gait, slight decreases of locomotor activity. |
Applicant's summary and conclusion
- Interpretation of results:
- other: Not classified (CLP Regulation EC no. 1272/2008)
- Conclusions:
- The oral-LD50 for the test substance in female rats was greater than 2000 mg/kg bw.
- Executive summary:
An acute toxicity study was conducted with the test item according to the fixed dose procedure specified in OECD guideline 420 and EU Method B.1.bis, under GLP conditions. Since no data was available, the preliminary experiment started with the administration of the test item suspended in corn oil at a dose of 300 mg/kg b.w. to one animal. Since no evident toxicity was observed at 300 mg/kg bw, the test item at a single dose of 2000 mg/kg b.w. was administered to the second animal. On the grounds of the preliminary experiment results, the dose of 2000 mg/kg bw was selected to be used in the main experiment and it was applied to four further rats. The observation period consisted of 14 days and included detailed clinical observations, body weight gain records and gross examinations at termination. In the main experiment (2000 mg/kg bw) changes in the body posture, the gait, and the locomotor activity were observed in all animals. The animals survived the experiment. Gross examinations did not reveal any pathological changes in the examined animals. Under the conditions of this study, the acute oral LD50 was determined to be greater than 2000 mg/kg bw in female rats
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.